Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy

Acta Ophthalmologica

Volumn 89, Issue 3, 2011, Pages

  Lee, Joo Yong ^a   Chae, Ju Byung ^a   Yang, Sung Jae ^a   Kim, June Gone ^a   Yoon, Young Hee ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

ADULT; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA FOVEA; SUBRETINAL FLUID; TREATMENT OUTCOME; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79954989279     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01835.x     Document Type: Letter

References (4)

1. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, &, Lam DS, (2008): Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28: 85-93.
2. Maier M, Valet V, Feucht N, Fiore B, Mohrenfels CWV, &, Lohmann C, (2008): Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for central serous chorioretinopathy: a case series. Acta Ophthalmol 86. Special Issue: Abstracts from the 2008 European Association for Vision and Eye Research Conference.
3. Orobia AM, Alperte JI, Alaman AS, Gabas JM, Lafuente N, &, Cristobal J, (2008): Photodynamic therapy without verteporfin for central serous chorioretinopathy. Acta Ophthalmol 86. Special Issue: Abstracts from the 2008 European Association for Vision and Eye Research Conference.
4. Torres-Soriano M, García-Aguirre G, Kon-Jara V, Ustariz-Gonzáles O, Abraham-Marín M, Ober M, &, Quiroz-Mercado H, (2008): A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports). Graefes Arch Clin Exp Ophthalmol 249: 1235-1239.